December 2, 2020, Singapore — Neeuro virtually exhibits CogoLand in the annual International Child and Adolescent Psychiatry (IACAPAP) Conference from December 2 to December 4, 2020 to showcase collaborative research work.

Early this year, the IACAPAP physical live congress had been postponed and converted to a virtual conference. As a continuing commitment of IACAPAP to engage the child and adolescent psychiatrists and allied professionals worldwide, a virtual congress was organized ato bring everyone together amidst the global situation.

To help support research education for healthcare professionals who have stepped up during these times, Neeuro joins this prestigious event in the most appropriate platform for healthcare professionals to continue sharing, discussing, and learning from one another.

Neeuro Demonstrates the SenzeBand and Digital Mental Health CogoLand Solution

CogoLand is a locally developed game that was created based on BCI technology developed at A*STAR’s Institute for Infocomm Research (I2R). Neeuro licensed the technology that created CogoLand and developed it into a commercial product, which consists of the SenzeBand headband to track brain signals as well as the CogoLand mobile application.

The aim of the game is to move a character through a maze. Unlike most games where users use a gamepad or touchscreen, the character’s movements can only be controlled by brainwaves. By keeping the mind focused on the character, the character moves forward. A loss of focus results in the character slowing down or remaining stationary. At higher levels, the user also needs to hit a button on the touchscreen to make the character jump while moving at the same time.


Users will be required to pair the CogoLand mobile application with a Neeuro SenzeBand for the detection of brainwaves. The user wears the SenzeBand headband, which has six sensors to track his/her brainwaves. Machine learning algorithms will capture and interpret the mental states of users based on their brainwaves, and these subsequently drive various challenges within the game.

Brainwaves and health data are captured through the SenzeBand headband and will be transmitted in real-time via Bluetooth wireless technology to CogoLand. 

“Our aim in utilising technology to enable positive change in the neurological abilities of our mental health practitioners’ clients has been amplified through this event. We are grateful for this opportunity with IACAPAP and IMH. ”
– Dr. Alvin Chan, Neeuro’s Co-Founder and Chief Executive Officer

Neeuro, which opened its HQ in Singapore in 2015, has also conducted a range of brain training workshops that seeks to train and develop local tech talent.  To find out more about Neeuro’s product offerings, please click here.

About Neeuro

Neeuro is a global company that specialises in the utilisation of Brain-Computer Interface technology to maximise the potential of users’ neurological agility and fitness. Neeuro’s extensive portfolio and an array of offerings empower digital therapeutics and brain fitness solutions and are backed with clinically validated research by A*STAR, an institution widely known as being at the forefront of Singapore’s research endeavours.

Its core technology, NeeuroOS, is a platform ecosystem that empowers health care professionals, researchers, and third-party developers with an Artificial Intelligence (AI) driven platform with the ability to analyse the brain signals of users; measuring mental states including but not limited to attention, relaxation, mental workload, and fatigue. Neeuro’s holistic platform, coupled with its other offerings, reveals numerous potential avenues to explore complementary mental wellness options for ADHD children, patients with stroke, cognitive rehabilitation, and many other neurological issues.


The International Association for Child and Adolescent Psychiatry and Allied Professions’ (IACAPAP) mission is to advocate for the promotion of the mental health and development of children and adolescents through policy, practice, and research. The IACAPAP also promotes the study, treatment, care, and prevention of mental and emotional disorders and disabilities involving children, adolescents, and their families with the emphasis on collaboration among the professions of child and adolescent psychiatry, psychology, social work, pediatrics, public health, nursing, education, social sciences, and other relevant disciplines.

About IMH

The Institute of Mental Health (IMH), a member of the National Healthcare Group, is the only tertiary psychiatric care institution in Singapore. Located on the sprawling 23-hectare campus of Buangkok Green Medical Park in the north-eastern part of Singapore, IMH offers a multidisciplinary and comprehensive range of psychiatric, rehabilitative, and therapy services in hospital-based and community-based settings. The 2010-bedded hospital aims to meet the needs of three groups of patients – children and adolescents (aged below 19 years), adults, and the elderly. Besides providing clinical services, IMH also leads to mental health research and training the next generation of mental health professionals in Singapore.


Stay Up to Date with the Latest News!

Learn all about brain fitness and receive exclusive offers. Sign up today!

Thank you for submitting the form!